borderline significantp = 0.085
controls ( p < 0.001) and were borderline significant for the comparison between PD vs. controls ( p = 0.085).
controls ( p < 0.001) and were borderline significant for the comparison between PD vs. controls ( p = 0.085).
There was also a nonsignificant trend of calprotectin levels being higher in MSA patients than in PD patients.